Click Here to return To Results

 

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer NEJM 382:1599-1607,1650, Agnelli, G.,et al, 2020 See this aricle in Pubmed Article Abstract Oral apixaban was noninferior to subcutaneous dalteparin for the treatment of cancer-associated venous thromboembolism without an increased risk of major bleeding.

Related Tags

(click to filter results - removes previous filter) anticoagulant,treatment apixaban cancer associated hypercoagulation carcinoma efficacy factor Xa inhibitor non-vitamin K antagonist oral anticoagulants safety thrombophlebitis treatment of neurologic disorder venous thrombosis,non-cerebral

Click Here to return To Results